What is PharmFilm technology?
PharmFilm technology is a novel drug delivery platform that provides precise dosing in the form of a quick-dissolving, taste-masked, and easy-to-administer dissolvable oral film.
What does aquestive therapeutics inc do?
Aquestive is a pharmaceutical company that advances and commercializes medicines to solve therapeutic problems and meaningfully improve people’s lives. We apply innovative drug delivery technology and scientific expertise to redesign important medicines.
Should I buy AQST stock?
There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Aquestive Therapeutics stock.
Will AQST get FDA approval?
Aquestive opened the IND for AQST-109 after receiving FDA clearance in February 2022. The Company anticipates conducting an end of Phase 2 meeting with the FDA and commencing the pivotal PK study in the second half of 2022.
Is AQST a buy?
The consensus among 2 Wall Street analysts covering (NASDAQ: AQST) stock is to Strong Buy AQST stock.
Is AQST a strong buy?
Will AQST go up?
The 5 analysts offering 12-month price forecasts for Aquestive Therapeutics Inc have a median target of 9.00, with a high estimate of 17.00 and a low estimate of 7.00. The median estimate represents a +800.00% increase from the last price of 1.00.
Is iQSTEL a good stock to buy?
iQSTEL Inc. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.
Is AQST stock a buy?
Aquestive Therapeutics has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Is Acasti Pharma a good buy?
Acasti Pharma Inc (NASDAQ:ACST) The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +471.23% increase from the last price of 0.88.
Should I buy ZSAN stock?
Out of 1 analyst, 0 (0%) are recommending ZSAN as a Strong Buy, 0 (0%) are recommending ZSAN as a Buy, 1 (100%) are recommending ZSAN as a Hold, 0 (0%) are recommending ZSAN as a Sell, and 0 (0%) are recommending ZSAN as a Strong Sell. What is ZSAN’s Earnings Per Share (EPS) forecast for 2022-2022?
Will Acasti Pharma go up?
The Wall Street analyst predicted that ACASTI PHARMA’s share price could reach $6.00 by Dec 22, 2022. The average ACASTI PHARMA stock price prediction forecasts a potential upside of 471.43% from the current ACST share price of $1.05.